Skip to main content
. Author manuscript; available in PMC: 2024 Jan 5.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Jul 5;32(7):963–975. doi: 10.1158/1055-9965.EPI-22-1274

Table 5.

Multivariable Cox proportional hazards models for the associations of changes in lifestyle on all-cause mortality, breast cancer-mortality, and breast cancer recurrence in the Pathways Study.

All-Cause Mortality Breast Cancer-Specific Mortality Breast Cancer Recurrence
Concordance Level # events HRa (95%CI) # events HRa (95%CI) # events HRa (95%CI)
Maintained Lowb 69 1.00 (–) 24 1.00 (–) 34 1.00 (–)
Maintained Partialc 45 0.89 (0.61, 1.30) 9 0.66 (0.30, 1.43) 29 0.87 (0.52, 1.43)
Maintained Highd 19 0.61 (0.37, 1.03) 4 0.51 (0.17, 1.49) 20 0.86 (0.49, 1.52)
Increasede 57 0.91 (0.64, 1.31) 17 0.98 (0.52, 1.86) 39 0.89 (0.56, 1.42)
Decreasedf 52 0.78 (0.54, 1.13) 16 0.70 (0.37, 1.33) 30 0.77 (0.47, 1.26)

Abbreviations: CI, confidence intervals; HR, hazard ratio

a

Adjusts for age, tumor stage, ER status, chemotherapy, Herceptin, radiation, comorbidities, smoking status, income, and education level.

b

Participant in lowest category of guideline concordance (lifestyle score <7) at both baseline and 2 years post-diagnosis.

c

Participant in the middle category of guideline concordance (lifestyle score 8–10) at both baseline and 2 years post-diagnosis.

d

Participant in the highest category of guideline concordance (lifestyle score 11+) at both baseline and 2 years post-diagnosis.

e

Participant increased category of guideline concordance from baseline to 2 years post-diagnosis (e.g., participant went from being in the lowest category of concordance at baseline to being in the middle category 2 years post-diagnosis).

f

Participant decreased category of guideline concordance from baseline to 2 years post-diagnosis (e.g., participant went from being in the highest category of concordance at baseline to being in the middle category 2 years post-diagnosis).